Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized study

Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized study

Background: Chemotherapy plus granulocyte colony-stimulating factor (GCSF) regimen is one of the available approaches to mobilize peripheral blood progenitor cells (PBPCs). It causes thrombocytopenia and delays leukapheresis. This study aimed to evaluate the role of recombinant human thrombopoietin...

Full description

Bibliographic Details
Main Authors: Hongnan Mo, Peng Liu, Yan Qin, Xiaohui He, Xiaohong Han, Jiarui Yao, Weicai Su, Shuxiang Zhang, Le Tang, Fengyi Zhao, Lin Gui, Sheng Yang, Jianliang Yang, Shengyu Zhou, Zhishang Zhang, Yuankai Shi
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2021-09-01
Series:Chronic Diseases and Translational Medicine
Subjects:
Recombinant human thrombopoietin
Mobilization
Lymphoma
Schedule
Online Access:http://www.sciencedirect.com/science/article/pii/S2095882X21000438

Internet

http://www.sciencedirect.com/science/article/pii/S2095882X21000438

Similar Items